LPM-3480226

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameLPM-3480226
Drug Alias NameDesvenlafaxine prodrugLPM-3480226LY-01013
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitorsTryptophan 2,3-dioxygenase inhibitors
TargetsTryptophan 2,3-dioxygenaseIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLuye Pharma Group Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Kanghai Phospholipid Biotechnology Co Ltd
Inactive CompaniesLuye Pharma Group Ltd
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A